. Author manuscript; available in PMC: 2010 Jun 1.

Published in final edited form as: Mod Pathol. 2009 Jun;22(6):833–838. doi: 10.1038/modpathol.2009.42

Table 5.

Differential use of V1-2 and V4-34 segments

Cell Types	V1-2	V4-34
Peripheral blood B-cells	3%^**	3%^**
Mutated CLL	7% (3/46)^*	20% (9/46)^*
Unmutated CLL	8% (3/38)^*	3% (1/38)^*
Splenic Marginal Zone Lymphoma	42% (20/48)^§	15% (7/48) ^§
1° CNS Lymphoma	0% (0/15)^¶	60% (9/15) ^¶
Other MALT Lymphomas (gastric, salivary gland, lung)	1% (1/76)^¥	4% (3/76) ^¥

^**

Brezinschek et al. ²³

Hamblin et al. ²⁵

^§

Bahler et al. ²⁹, & Algara et al. ²⁸

^¶

Thompsett et al. ²⁷ , & Montesions-Rongen et al. ²⁶

^¥

Bende et al. ¹², Sakuma et al. ³¹, & Lenze et al. ³⁰